| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66532283 |
| PharmacoGx | BRD-K66532283 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SLC16A14 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | RAD51AP1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | UFM1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | TBC1D2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | NPDC1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | BORCS7 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | WAC | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | SSBP2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | FRK | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | VHLL | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
